Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03982563
Other study ID # 24922
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 31, 2019
Est. completion date June 4, 2020

Study information

Verified date June 2020
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall aim of this project is to understand if single-session interventions are acceptable, culturally appropriate, and effective for Indian adolescents. The investigators will be examining the effects of three interventions on the well-being and mental health of adolescents. The investigators hypothesize that at least one of the three interventions will yield statistically significant improvements in wellbeing and mental health relative to a study skills control condition.


Recruitment information / eligibility

Status Completed
Enrollment 958
Est. completion date June 4, 2020
Est. primary completion date March 15, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Years to 18 Years
Eligibility Inclusion Criteria:

- Attending a participating secondary school

- Age 12 to 18

- Literate in English

Exclusion Criteria:

- Unable to provide informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Growth Mindset
Reading and writing activities designed to instill the belief that people can change.
Gratitude
Reading and writing activities designed to practice noticing and appreciating good things in life.
Behavioral Activation
Reading and writing activities designed to identify and schedule positive activities.
Study Skills
Reading and writing activities designed to learn evidence-based study strategies.

Locations

Country Name City State
India Dr. Kalmadi Junior High School Pune Maharashtra
India Modern College Pune Pune
India The Orchid School Pune Maharashtra
India JM Rathi English School Roha Maharashtra

Sponsors (2)

Lead Sponsor Collaborator
University of Pennsylvania Sangath

Country where clinical trial is conducted

India, 

References & Publications (4)

Chorpita BF, Becker KD, Daleiden EL. Understanding the common elements of evidence-based practice: misconceptions and clinical examples. J Am Acad Child Adolesc Psychiatry. 2007 May;46(5):647-52. — View Citation

Emmons RA, McCullough ME. Counting blessings versus burdens: an experimental investigation of gratitude and subjective well-being in daily life. J Pers Soc Psychol. 2003 Feb;84(2):377-89. — View Citation

Schleider J, Weisz J. A single-session growth mindset intervention for adolescent anxiety and depression: 9-month outcomes of a randomized trial. J Child Psychol Psychiatry. 2018 Feb;59(2):160-170. doi: 10.1111/jcpp.12811. Epub 2017 Sep 18. — View Citation

Seligman ME, Steen TA, Park N, Peterson C. Positive psychology progress: empirical validation of interventions. Am Psychol. 2005 Jul-Aug;60(5):410-21. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in The Warwick-Edinburgh Mental Wellbeing Scale Well-being questionnaire. Total score ranges from 14 to 70. Higher values indicate a better outcome. Baseline, 4 week follow-up, 12 week follow-up
Primary Intervention Appropriateness Measure Questionnaire measuring the appropriateness of an intervention. Appropriateness refers to the perceived fit or relevance of an intervention. The total score ranges from 4 to 20. Higher scores indicate a better outcome. Immediately post-intervention (i.e., 0 weeks)
Secondary Patient Health Questionnaire-9 Depression Questionnaire. The total score ranges from 0 to 27. Lower scores indicate a better outcome. Baseline, 4 week follow-up, 12 week follow-up
Secondary Generalized Anxiety Disorder Screener-7 Anxiety Questionnaire. The total score ranges from 0 to 21. Lower scores indicate a better outcome. Baseline, 4 week follow-up, 12 week follow-up
Secondary The EPOCH Measure of Adolescent Well-being Questionnaire with five subscales measuring engagement, perseverance, optimism, connectedness, and happiness. Each subscale score ranges from 4 to 20. Higher scores indicate a better outcome. The happiness and optimism subscales will be used as secondary outcomes for this trial. A total score is not computed. Baseline, 4 week follow-up, 12 week follow-up
Secondary Acceptability of Intervention Measure Questionnaire measuring the acceptability of an intervention. Acceptability refers to the perception that a given treatment is agreeable or satisfactory. The total score ranges from 4 to 20. Higher scores indicate a better outcome. Immediately post-intervention (i.e., 0 weeks)
Secondary Feasibility of Intervention Measure Questionnaire measuring the feasibility of an intervention. Feasibility refers to the degree to which a treatment can be successfully implemented in a given setting. The total score ranges from 4 to 20. Higher scores indicate a better outcome. Immediately post-intervention (i.e., 0 weeks)
Secondary Perceived Stress Scale-4 Questionnaire measuring perceived stress. The total score ranges from 0 to 16. Lower scores indicate a better outcome. Baseline, 4 week follow-up, 12 week follow-up
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A